Runx2 Regulated Airway Homeostasis Is Disrupted in Asthma

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Molecular Biology

Background:

• Airway remodeling, characterized by increased airway smooth muscle (ASM) bulk, is a hallmark of asthma.
• Transforming growth factor (TGF)-β1 and connective tissue growth factor (CTGF) are key mediators promoting ASM remodeling.
• Runt-related transcription factor-2 (RUNX2) is known to repress TGF-β1-induced CTGF via SMAD3 interactions.

Purpose of the Study:

• To investigate the expression and functional role of RUNX2 in asthmatic versus nonasthmatic ASM cells.
• To explore the impact of RUNX2 modulation on airway inflammation and remodeling markers in asthma.

Main Methods:

• Quantitative analysis of RUNX2 mRNA and protein in isolated ASM cells and lung tissues using microarray, PCR, western blot, and immunohistochemistry.
• Overexpression of RUNX2 isoforms in immortalized asthmatic ASM cells to assess effects on inflammation and remodeling markers.
• Analysis of RUNX2 alternative splicing in bronchial biopsies from asthmatic and healthy individuals.

Main Results:

• RUNX2 abundance was significantly reduced in ASM cells from asthmatic patients compared to nonasthmatic controls.
• TGF-β1 stimulation differentially affected RUNX2 expression in nonasthmatic versus asthmatic ASM cells, impacting SMAD3 activation.
• RUNX2 isoform overexpression in asthmatic ASM cells reduced markers of remodeling (CTGF), hypertrophy, and proliferation, without affecting IL-6 levels.
• Increased RUNX2 mRNA splicing was observed in asthmatic bronchial biopsies.

Conclusions:

• RUNX2 plays a crucial role in maintaining airway smooth muscle homeostasis in healthy individuals.
• Reduced RUNX2 expression in asthma contributes to airway smooth muscle remodeling.
• Restoration of RUNX2 function presents a potential therapeutic avenue for asthma treatment.